Press Release: End Well’s “The End in Mind” Conference to Explore Psychedelics’ Role in Improving the End of Life Experience

CANNANNEW REPORT

  Free and open to the public virtual event on Thursday, Oct. 14th will bring together changemaking celebrities like Melissa Etheridge and Van Jones, along with healthcare, business, policy, culture and psychedelic leaders to discuss how psychedelics can transform the end of life into a human-centered experience   SAN FRANCISCO, September 8, 2021 — End Well, a 501(c)3 nonprofit dedicated to the belief that all people should experience the end of life in a way that matches their values and goals, announced it will host The End in Mind, the largest mainstream gathering to date dedicated to the future of psychedelic medicines in care for people facing serious illness or end of life on Thursday, October 14th.   The virtual event, which is currently free and open to the public, will bring together changemaking celebrities like GRAMMY® winner Melissa Etheridge and Dream Corps founder Van Jones, along with healthcare, policy, culture, business and psychedelic leaders. The End in Mind’s conference tracks will explore a range of topics, including: psychedelic medicines and their uses, from age-old Indigenous practices to the latest clinical trials; the current and future role of psychedelics in care for serious illness, grief, and end of life; the science behind psychedelics and their potential to help treat mental, physical, and social conditions; stigmas surrounding the consumption of psychedelic substances; the policy landscape and emerging market for psychedelic medicines; and the growing movement to broaden access to these treatments.   The conference’s robust lineup of speakers include:   Van Jones, activist, changemaker and founder of Dream Corps; Melissa Etheridge, singer-songwriter, guitarist, GRAMMY® winner, activist and entrepreneur; Rick Doblin, Ph.D., American drug reformist, advocate and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS); Stephen Ross, MD, psychiatrist, psychedelics researcher, and associate director of NYU Langone’s…

Excerpt only …
READ MORE BELOW
Source : Press Release: End Well’s “The End in Mind” Conference to Explore Psychedelics’ Role in Improving the End of Life Experience

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.